# OnCo record stk-012 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/stk-012/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "stk-012" ;
  schema:name "STK-012"@en ;
  schema:description "STK-012 is an experimental engineered immune-signalling protein from Synthekine, in phase 2 trials for non-small cell lung cancer."@en ;
  schema:url <https://onco.cc/drugs/stk-012/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.synthekine.com/our-pipeline/>, <https://clinicaltrials.gov/study/NCT05098132> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Engineered cytokine (interleukin-2 partial agonist)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/cd25/>, <https://onco.cc/targets/il2rb/> ;
  onco:companies <https://onco.cc/companies/synthekine/> ;
  onco:trials <https://onco.cc/trials/nct05098132/> .